Search

everythinglearnresearchcommunity

for

Search:↓

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Abatacept may help some people with alopecia areata regrow hair.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Bimekizumab effectively treated a man's chronic beard hair loss.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

JAK inhibitors are effective treatments for alopecia areata.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Adalimumab may cause severe hair loss in some patients.

Rituximab improved her dermatomyositis better than usual treatments.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.